Stephanos Ioannidis
Signal active
EVP, Drug Discovery
Contact Information
Social
Primary Organization
Exo Therapeutics
Founded
2018
Employees
11-50
Industry
Biotechnology, Health Care, Pharmaceutical
Bio
Stephanos Ioannidis is the current EVP, Drug Discovery of Exo Therapeutics. He previously worked at IFM Therapeutics as an EVP, Head of Discovery. Stephanos Ioannidis attended Harvard University.
Location
Cambridge, Massachusetts, United States, North America
Jobs history
1
Exo Therapeutics
EVP, Drug Discovery
2022 - Current
Educations
1
Harvard University
Organic Chemistry
Profile Resume
Stephanos Ioannidis is the EVP, Drug Discovery at Exo Therapeutics, based in United States, North America. With a background in Biotechnology, Stephanos Ioannidis has a rich history of leadership and innovation.Stephanos Ioannidis studied PostDoctoral Studies Organic Chemistry at Harvard University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.